Status:
UNKNOWN
Study of Circulating and Tumor Biomarkers in Breast Cancer Patients
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Breast Cancer
Eligibility:
FEMALE
21+ years
Brief Summary
Aims: To evaluate the role of monoclonal antibodies in the detection of cancer specific antigens in blood and tumor tissue, and the potential use of these antibodies for future evaluation for therapy....
Eligibility Criteria
Inclusion
- Advanced breast cancer patients whose cancer have progressed and are due to start a new course of anti-cancer therapy.The patient needs to have had previous breast cancer surgery at NUH (lumpectomy or mastectomy) or a diagnostic core biopsy for breast cancer, and consent to allow for blood taking and access to archival tissue.
Exclusion
- No available archival tumor specimen at NUH.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01866202
Start Date
March 1 2012
Last Update
December 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationa University Hospital
Singapore, Singapore